Imagine if there was a way to resolve two of the most intractable challenges in the 340B program in one fell swoop: one that has a significant impact on the financial health of 340B providers, and another that affects the pharmaceutical industry’s bottom line? It may be hard to imagine, but there is now a bill in Congress that can be welcomed by both the 340B covered entity community and the drug industry.
The combination of EnlivenHealth and FDS Amplicare will help us advance and accelerate our mission to build and orchestrate the most advanced digital engagement technologies designed to help retail pharmacies and health plans keep their patients and members healthy, while strengthening business results.
One area of opportunity to enhance pharmacy practice is the implementation of technology. The status quo is failing both practitioners and patients. How are leading health systems assessing their medication management strategy to identify opportunities for improvement?
Pharmacy transformations are happening every day. As leaders, we need to identify the challenges that need to be addressed in order to not only deliver improved patient care, but to elevate clinician satisfaction, and optimize pharmacy performance.
By connecting medication inventory and leveraging the data pulled from that technology, there is a huge opportunity to reduce error, improve efficiency, control costs, ensure compliance and, ultimately, enhance patient care and safety.
It’s been almost one year mark since a group of drug manufacturers stopped offering 340B discounts or placed restrictions on these discounts in the contract pharmacy setting. So what are the burning questions that continue to remain in this standoff?
Join us for Omnicell Illuminate 2021, a dynamic, three-day digital conference focused on the most pressing challenges in medication management: operational efficiency, diversion, medication waste, safety, compliance, and increasing revenue, just to name a few.
Some may think of the ADC as simply a storage unit for nursing, but in reality it plays a critical role across the medication management ecosystem. As ADC systems have evolved, some are now connected to sophisticated data intelligence systems, helping them to play a more prominent role in optimizing pharmacy inventory.
With drug costs skyrocketing and the ever-present challenge of drug shortages, throwing away medications can be agonizing. And costly. The more visibility you have into your inventory, the better equipped you are to eliminate medication waste and ensure clinicians have access to the medications patients need.
The views and opinions expressed in this blog are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s). These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.